CellaVision AB engages in the provision of digital microscopy solutions for hematology laboratories. The company is headquartered in Lund, Skane and currently employs 228 full-time employees. The company went IPO on 2007-05-28. The firm develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The firm operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.
Follow-Up Questions
CLVSF hissesinin fiyat performansı nasıl?
CLVSF 'in mevcut fiyatı $0 'dir, son işlem günde 0% decreased etti.
CellaVision AB için ana iş temaları veya sektörler nelerdir?
CellaVision AB Health Care endüstrisine ait ve sektör Health Care 'dir
CellaVision AB 'in piyasa değerlemesi nedir?
CellaVision AB 'in mevcut piyasa değerlemesi $0 'dir
CellaVision AB al, sat, yoksa beklemeli mi?
Wall Street analistlerine göre, 5 analist CellaVision AB için analist derecelendirmeleri gerçekleştirdi, bunlar 2 güçlü al, 5 al, 1 tut, 0 sat ve 2 güçlü sat içermektedir
